Open Access
Volume 8, Number 1, March 2018
Article Number 4
Number of page(s) 7
Published online 26 February 2018
  1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. WHO international agency for research on cancer monograph working group. Lancet Oncol. 2009; 10: 321-2. [CrossRef] [PubMed] [Google Scholar]
  2. Manzo-Merino J, Contreras-Paredes A, Vázquez-Ulloa E, Rocha-Zavaleta L, Fuentes-Gonzalez AM, Lizano M. The role of signaling pathways in cervical cancer and molecular therapeutic targets. Arch Med Res. 2014; 45: 525-39. [CrossRef] [PubMed] [Google Scholar]
  3. Workman JL, Kingston RE. Alteration of nucleosome structure as a mechanism of transcriptional regulation. Annu Rev Biochem. 1998; 67: 545-79. [CrossRef] [PubMed] [Google Scholar]
  4. Wolffe AP. Chromatin remodeling: why it is important in cancer. Oncogene. 2001; 20: 2988-90. [CrossRef] [PubMed] [Google Scholar]
  5. Lafon-Hughes L, Di Tomaso MV, Méndez-Acuña L. Chromatin-remodeling mechanisms in cancer. Mutat Res. 2008; 658: 191-214. [CrossRef] [PubMed] [Google Scholar]
  6. Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer. Part II: ATP-dependent chromatin remodeling. Trends Mol Med. 2007; 13: 373-80. [CrossRef] [PubMed] [Google Scholar]
  7. Längst G, Manelyte L. Chromatin remodelers: From function to dysfunction. Genes. (Basel) 2015; 6: 299-324. [CrossRef] [PubMed] [Google Scholar]
  8. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013; 339: 1546-58. [CrossRef] [PubMed] [Google Scholar]
  9. Gonzalez-Perez A, Jene-Sanz A, Lopez-Bigas N. The mutational landscape of chromatin regulatory factors across 4,623 tumor samples. Genome Biol. 2013; 14: r106. [CrossRef] [PubMed] [Google Scholar]
  10. Shih IeM, Sheu JJ, Santillan A, Nakayama K, Yen MJ, Bristow RE, et al. Amplification of a chromatin remodeling gene, RSF-1/HBX-AP, in ovarian carcinoma. Proc Natl Acad Sci U S A. 2005; 102: 14004-9. [CrossRef] [PubMed] [Google Scholar]
  11. Li Q, Dong Q, Wang E. RSF-1 is overexpressed in non-small cell lung cancers and regulates cyclinD1 expression and ERK activity. Biochem Biophys Res Commun. 2012; 420: 6-10. [CrossRef] [Google Scholar]
  12. Liu S, Dong Q, Wang E. RSF-1 overexpression correlates with poor prognosis and cell proliferation in colon cancer. Tumour Biol. 2012; 33: 1485-91. [CrossRef] [PubMed] [Google Scholar]
  13. Li H, Zhang Y, Zhang Y, Bai X, Peng Y, He P. RSF-1 overexpression in human prostate cancer, implication as a prognostic marker. Tumour Biol. 2014; 35: 5771-6. [CrossRef] [PubMed] [Google Scholar]
  14. Xie C1, Fu L, Xie L, Liu N, Li Q. RSF-1 overexpression serves as a prognostic marker in human hepatocellular carcinoma. Tumour Biol. 2014; 35: 7595-601. [CrossRef] [PubMed] [Google Scholar]
  15. Davidson B1, Trope' CG, Wang TL, Shih IeM. Expression of the chromatin remodeling factor RSF-1 is up-regulated in ovarian carcinoma effusions and predicts poor survival. Gynecol Oncol. 2006; 103: 814-9. [CrossRef] [PubMed] [Google Scholar]
  16. Hu BS, Yu HF, Zhao G, Zha TZ. High RSF-1 expression correlates with poor prognosis inpatients with gastric adenocarcinoma. Int J Clin Exp Pathol. 2012; 5: 668-73. [PubMed] [Google Scholar]
  17. Fang FM, Li CF, Huang HY, Lai MT, Chen CM, Chiu IW, et al. Overexpression of a chromatin remodeling factor, RSF-1/HBXAP, correlates with aggressive oral squamous cell carcinoma. Am J Pathol. 2011; 178: 2407-15. [CrossRef] [PubMed] [Google Scholar]
  18. Maeda D, Chen X, Guan B. RSF-1 (HBXAP) expression is associated with advanced stage and lymph node metastasis in ovarian clear cell carcinoma. Int J Gynecol Pathol. 2011; 30: 30-5. [CrossRef] [PubMed] [Google Scholar]
  19. Choi JH, Sheu JJ, Guan B, Jinawath N, Markowski P, Wang TL, et al. Functional analysis of 11q13.5 amplification identifies RSF-1 (HBXAP) as a gene involved in paclitaxel resistance in ovarian cancer. Cancer Res. 2009; 69: 1407-15. [CrossRef] [Google Scholar]
  20. Sheu JJ, Choi JH, Yildiz I, Tsai FJ, Shaul Y, Wang TL, et al. The roles of human sucrose nonfermenting protein 2 homologue in the tumor-promoting functions of Rsf-1. Cancer Res. 2008; 68: 4050-7. [CrossRef] [Google Scholar]
  21. Sheu JJ, Choi JH, Yildiz I, Tsai FJ, Shaul Y, Lai MT, et al. Rsf-1, a chromatin remodelling protein, interacts with cyclin E1 and promotes tumour development. J Pathol. 2013; 229: 559-68. [CrossRef] [PubMed] [Google Scholar]
  22. Sheu JJ, Guan B, Choi JH, Lin A, Lee CH, Hsiao YT, et al. Rsf-1, a chromatin remodeling protein, induces DNA damage and promotes genomic instability. J Biol Chem. 2010; 285: 38260-9. [CrossRef] [PubMed] [Google Scholar]
  23. Pessina F, Lowndes NF. The RSF1 histone-remodelling factor facilitates DNA double-strand break repair by recruiting centromeric and Fanconi Anaemia proteins. PLoS Biol. 2014; 12: e1001856. [CrossRef] [PubMed] [Google Scholar]
  24. Helfricht A, Wiegant WW, Thijssen PE, Vertegaal AC, Luijsterburg MS, van Attikum H. Remodeling and spacing factor 1 (RSF1) deposits centromere proteins at DNA double-strand breaks to promote non-homologous end-joining. Cell Cycle. 2013; 12: 3070-82. [CrossRef] [PubMed] [Google Scholar]
  25. Zhao XC, An P, Wu XY, Zhao XC, An P, Wu XY, et al. Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemoresistance through its interaction with Rsf-1. Tumour Biol. 2016; 37: 7203-12. [CrossRef] [PubMed] [Google Scholar]
  26. Shamay M, Barak O, Doitsh G, Ben-Dor I, Shaul Y. Hepatitis B virus pX interacts with HBXAP, a PHD finger protein to coactivate transcription. J Biol Chem. 2002; 277: 9982-8. [CrossRef] [PubMed] [Google Scholar]
  27. Shamay M, Barak O, Shaul Y. HBXAP, a novel PHD-finger protein, possesses transcription repression activity. Genomics. 2002; 79: 523-9. [CrossRef] [PubMed] [Google Scholar]